Drug company accused of ‘disguised marketing’ - and why we all need to be aware of industry funding of patient advocacy groups
Wednesday, October 25th, 2006Last week’s blog and newsletter featured ‘a little bit of politics’. Here, I highlighted the evidence that the pharmaceutical industry can bias the results of ‘scientific’ endeavour, and I also drew attention to the conflict of interest that exists between this drug companies the medical journals that publish and help popularise their research. […]

